Mastodon

Septolete® (Pastilles) Instructions for Use

ATC Code

R02AA20 (Other antiseptics)

Clinical-Pharmacological Group

A drug with antimicrobial and anti-inflammatory action for topical use in ENT practice and dentistry

Pharmacotherapeutic Group

Antiseptic

Pharmacological Action

A combined medicinal product for topical use.

Benzalkonium chloride and Thymol have antiseptic properties, are active against gram-positive bacteria, and have a fungicidal effect on Candida albicans and some lipophilic viruses.

Menthol and Peppermint oil have a moderate analgesic and deodorizing effect.

Eucalyptus oil reduces mucus secretion in the upper respiratory tract and facilitates breathing.

Indications

Use for the local treatment of infectious and inflammatory conditions affecting the oral cavity, pharynx, and larynx.

  • Infectious and inflammatory diseases of the oral cavity, pharynx, larynx: pharyngitis, laryngitis, tonsillitis.
  • Inflammation of the gums and oral mucosa (gingivitis, stomatitis).

ICD codes

ICD-10 code Indication
J02 Acute pharyngitis
J03 Acute tonsillitis
J04.0 Acute laryngitis
J31.2 Chronic pharyngitis
J35.0 Chronic tonsillitis
J37.0 Chronic laryngitis
K05 Gingivitis and periodontal diseases
K12 Stomatitis and related lesions
ICD-11 code Indication
CA02.Z Acute pharyngitis, unspecified
CA03.Z Acute tonsillitis, unspecified
CA05.0 Acute laryngitis
CA09.2 Chronic pharyngitis
CA0F.Y Other specified chronic diseases of the palatine tonsils and adenoids
CA0G Chronic laryngitis or laryngotracheitis
DA01.Z Diseases of the oral mucosa, unspecified
DA0B.Z Gingival diseases, unspecified
DA0C.Z Periodontal diseases, unspecified
DA0Z Diseases or disorders of the orofacial complex, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Administer by allowing the pastille to dissolve slowly in the mouth. Do not chew or swallow whole. A single dose is one pastille.

Take one pastille every 2-3 hours. Do not exceed the maximum daily dose. For adults and children over 12 years: up to 8 pastilles per day. For children over 10 years: up to 6 pastilles per day. For children over 4 years: up to 4 pastilles per day.

Adverse Reactions

Adverse reactions are generally infrequent and mild. From the digestive system: nausea, diarrhea.

Allergic reactions are possible in patients with known hypersensitivity to any component of the drug. Discontinue use immediately if signs of hypersensitivity, such as skin rash or itching, occur.

Contraindications

Do not use under any circumstances if any of the following conditions are present.

  • Known hypersensitivity to benzalkonium chloride, thymol, menthol, peppermint oil, eucalyptus oil, or any other component of the drug.
  • Children under 4 years of age due to the risk of choking and underdeveloped ability to use lozenges safely.

Drug Interactions

Avoid concurrent use with other antiseptic agents intended for dissolution in the oral cavity, as this may lead to mutual inactivation, particularly with benzalkonium chloride.

Do not take with milk, as it significantly reduces the antiseptic activity of benzalkonium chloride, compromising the therapeutic effect.

Overdose

Symptoms of overdose are related to the local effects of the components and may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea.

In case of accidental ingestion of a large number of pastilles, seek immediate medical attention or contact a Poison Control Center. Treatment is symptomatic and supportive.

Use in Pregnancy and Lactation

The use of the drug during pregnancy and breastfeeding is possible only on the recommendation of a doctor.

Pediatric Use

Contraindication: children under 4 years of age.

Special Precautions

It is not recommended to use simultaneously with milk, because milk reduces the antiseptic activity of benzalkonium chloride.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Krka, D.D. (Slovenia)

Packaged By

KRKA-RUS, LLC (Russia)

Dosage Form

Bottle OTC Icon Septolete® Lozenges: 30 pcs.

Dosage Form, Packaging, and Composition

Pastilles light green in color, with possible inclusions of white color, round, biconvex.

1 pastille
Benzalkonium chloride 1 mg
Levomenthol 1.2 mg
Peppermint oil 1 mg
Eucalyptus oil 600 mcg
Thymol 600 mcg

Excipients : lactose monohydrate, liquid paraffin, glycerol, castor oil, defoamer 1510, sorbitol, liquid dextrose (glucose) (dry substance), magnesium stearate, quinoline yellow dye (E104), indigo carmine blue dye (E132), titanium dioxide (E171), povidone, emulsifying wax, sucrose.

10 pcs. – blisters (3) – cardboard packs.
15 pcs. – blisters (2) – cardboard packs.

Marketing Authorization Holder

Krka, D.D. (Slovenia)

Packaged By

VECTOR-MEDICA, JSC (Russia)

Dosage Form

Bottle OTC Icon Septolete® Lozenges: 30 pcs.

Dosage Form, Packaging, and Composition

Pastilles light green in color, with possible inclusions of white color, round, biconvex.

1 pastille
Benzalkonium chloride 1 mg
Levomenthol 1.2 mg
Peppermint oil 1 mg
Eucalyptus oil 600 mcg
Thymol 600 mcg

Excipients : lactose monohydrate, liquid paraffin, glycerol, castor oil, defoamer 1510, sorbitol, liquid dextrose (glucose) (dry substance), magnesium stearate, quinoline yellow dye (E104), indigo carmine blue dye (E132), titanium dioxide (E171), povidone, emulsifying wax, sucrose.

10 pcs. – blisters (3) – cardboard packs.
15 pcs. – blisters (2) – cardboard packs.

Marketing Authorization Holder

Krka, D.D. (Slovenia)

Packaged By

KRKA, d.d. (Slovenia)

Dosage Form

Bottle OTC Icon Septolete® Lozenges: 30 pcs.

Dosage Form, Packaging, and Composition

Pastilles light green in color, with possible inclusions of white color, round, biconvex.

1 pastille
Benzalkonium chloride 1 mg
Levomenthol 1.2 mg
Peppermint oil 1 mg
Eucalyptus oil 600 mcg
Thymol 600 mcg

Excipients : lactose monohydrate, liquid paraffin, glycerol, castor oil, defoamer 1510, sorbitol, liquid dextrose (glucose) (dry substance), magnesium stearate, quinoline yellow dye (E104), indigo carmine blue dye (E132), titanium dioxide (E171), povidone, emulsifying wax, sucrose.

10 pcs. – blisters (3) – cardboard packs.
15 pcs. – blisters (2) – cardboard packs.

TABLE OF CONTENTS